{"entity":{"type":"insider","cik":"0001754403","url":"/insider/0001754403","json_url":"/insider/0001754403.json","name":"SCHMIDT ERIC THOMAS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":7,"first":"2020-03-18","last":"2022-03-17","span_basis":"filed_date"},"name_variants":[{"name":"SCHMIDT ERIC THOMAS","source":"filing","n_filings":7,"first_seen":"2020-03-18","last_seen":"2022-03-17"}],"transactions":[{"id":6466846,"accession":"0001214659-22-004084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-004084","line_url":"/filing/0001214659-22-004084#line-1","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001754403","owner_name":"SCHMIDT ERIC THOMAS","owner_display_name":"SCHMIDT ERIC THOMAS","owner_url":"/insider/0001754403","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11469.0,"shares_display":"11,469","price_per_share":7.6337,"price_display":"7.63","price_state":"stated","total_value":87550.9053,"total_display":"87,550.91","total_whole":"87,551","shares_owned_after":100546.0,"shares_owned_after_display":"100,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-17","scope":"insider"},{"id":4115529,"accession":"0001214659-21-003238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-21-003238","line_url":"/filing/0001214659-21-003238#line-1","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001754403","owner_name":"SCHMIDT ERIC THOMAS","owner_display_name":"SCHMIDT ERIC THOMAS","owner_url":"/insider/0001754403","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8053.0,"shares_display":"8,053","price_per_share":38.2328,"price_display":"38.23","price_state":"stated","total_value":307888.7384,"total_display":"307,888.74","total_whole":"307,889","shares_owned_after":71231.0,"shares_owned_after_display":"71,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":4748098,"accession":"0001214659-21-000617","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001214659-21-000617","line_url":"/filing/0001214659-21-000617","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001754403","owner_name":"SCHMIDT ERIC THOMAS","owner_display_name":"SCHMIDT ERIC THOMAS","owner_url":"/insider/0001754403","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":32.25725990666667,"price_display":"32.26","price_state":"stated","total_value":483858.8986,"total_display":"483,858.90","total_whole":"483,859","shares_owned_after":1152995.0,"shares_owned_after_display":"1,152,995","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider","n_lines":3},{"id":4748085,"accession":"0001214659-21-000617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-000617","line_url":"/filing/0001214659-21-000617","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001754403","owner_name":"SCHMIDT ERIC THOMAS","owner_display_name":"SCHMIDT ERIC THOMAS","owner_url":"/insider/0001754403","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":30.774017,"price_display":"30.77","price_state":"stated","total_value":461610.255,"total_display":"461,610.26","total_whole":"461,610","shares_owned_after":1172744.0,"shares_owned_after_display":"1,172,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-19","scope":"insider","n_lines":2},{"id":2051358,"accession":"0001214659-20-009726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-009726","line_url":"/filing/0001214659-20-009726","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001754403","owner_name":"SCHMIDT ERIC THOMAS","owner_display_name":"SCHMIDT ERIC THOMAS","owner_url":"/insider/0001754403","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":32.87642666666667,"price_display":"32.88","price_state":"stated","total_value":493146.4,"total_display":"493,146.40","total_whole":"493,146","shares_owned_after":1182595.0,"shares_owned_after_display":"1,182,595","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider","n_lines":2},{"id":2481035,"accession":"0001214659-20-008703","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001214659-20-008703","line_url":"/filing/0001214659-20-008703","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001754403","owner_name":"SCHMIDT ERIC THOMAS","owner_display_name":"SCHMIDT ERIC THOMAS","owner_url":"/insider/0001754403","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":40.492824633333335,"price_display":"40.49","price_state":"stated","total_value":607392.3695,"total_display":"607,392.37","total_whole":"607,392","shares_owned_after":1207491.0,"shares_owned_after_display":"1,207,491","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-16","scope":"insider","n_lines":5},{"id":3210794,"accession":"0001214659-20-008039","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-20-008039","line_url":"/filing/0001214659-20-008039","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001754403","owner_name":"SCHMIDT ERIC THOMAS","owner_display_name":"SCHMIDT ERIC THOMAS","owner_url":"/insider/0001754403","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":35.30298366666667,"price_display":"35.30","price_state":"stated","total_value":529544.755,"total_display":"529,544.76","total_whole":"529,545","shares_owned_after":1217706.0,"shares_owned_after_display":"1,217,706","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-21","filed_date":"2020-09-22","scope":"insider","n_lines":3},{"id":2254383,"accession":"0001214659-20-002735","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-002735","line_url":"/filing/0001214659-20-002735","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001754403","owner_name":"SCHMIDT ERIC THOMAS","owner_display_name":"SCHMIDT ERIC THOMAS","owner_url":"/insider/0001754403","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5450.0,"shares_display":"5,450","price_per_share":19.726211926605504,"price_display":"19.73","price_state":"stated","total_value":107507.855,"total_display":"107,507.86","total_whole":"107,508","shares_owned_after":47257.0,"shares_owned_after_display":"47,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737287","name":"Allogene Therapeutics, Inc.","url":"/issuer/0001737287","role":"Officer (Chief Financial Officer)","n_filings":7,"first_seen":"2020-03-18","last_seen":"2022-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001754403","retrieved_at":"2026-08-24T21:10:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}